| Chairman | Pierre Amarenco | Hopital Lariboisiere |
|
Introduction and interactive vote
|
|
Cholesterol and stroke: Lessions from epidemiology and intervention studies
|
|
Cholesterol reduction and stroke reduction: Mechanism of action
|
|
The effects of aggressive vs moderate lipid lowering on carotid IMT - the ASAP study
|
|
The potential role of atorvastatin in stroke prevention
|
|
Repeat of interactive vote and closing remarks
|